Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valchlor in Lichen Planopilaris
NCT03417141Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Apr 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mechlorethamine in lichen planopilaris (LPP), sponsored by Mayo Clinic. Started Apr 2018; status: completed.
02
Drugs
mechlorethamine
03
Conditions
lichen planopilaris (LPP)
Beyond the preview
Go deeper on NCT03417141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03417141.